September 10 Is World Suicide Prevention Day

Suicide is a devastating result of mental illness. The statistics regarding suicide are staggering—it is the eleventh leading cause of death in the United States, accounting for 33,000 deaths in 2006…

> Read entire article
> Download printable version
> Back to top

Compass Questions™

> Back to top

Responses from Last Compass Questions™

In the 08.25.09 issue of Clinical Compass™, we asked five questions.

Question #1 was "What percentage of your patients have difficulty adhering to your prescribed therapies?" and the neuroscienceCME learning community responded:
28.7% - 0-20%
31.0% - 20-40%
30.2% - 40-60%
8.5% - 60-80%
1.6% - 80-100%

Question #2 was "How often do you educate your patients about the importance of adherence?" and the neuroscienceCME learning community responded:
81.1% - Almost always
12.9% - Often
3.8% - Sometimes
2.2% - Rarely
0.0% - Very rarely

Question #3 was "How often do you provide your patients with resources to aid with adherence?" and the neuroscienceCME learning community responded:
35.9% - Almost always
37.4% - Often
15.3% - Sometimes
6.1% - Rarely
5.3% - Very rarely

Question #4 was "How often do you verify that patients understand what they need to do and why?" and the neuroscienceCME learning community responded:
61.1% - Almost always
28.2% - Often
9.2% - Sometimes
0.0% - Rarely
1.5% - Very rarely

Question #5 was "How often do you assess patient adherence on follow-up?" and the neuroscienceCME learning community responded:
59.2% - Almost always
23.9% - Often
11.5% - Sometimes
3.1% - Rarely
2.3% - Very rarely

> Back to top

New Sleep-Wake neuroscienceCME Journal Club Series!

Evolving Sleep-Wake Research: Implications for Improved Patient Outcomes, Parts 1-3

3 Chances for Live Interaction with Authors of Featured Articles!
Each part premieres on the following date/time:

PART 1: Tuesday, September 29, 2009
12:00-1:00 p.m. ET (Dr. Dijk/Dr. Roth)

Featured Article: Viola AU, Archer SN, James LM, et al. PER3 polymorphism predicts sleep structure and waking performance. Curr Biol 2007;17:613-618.

> View activity details
> View abstract
> Add to calendar
> Register now

PART 2: Monday, October 5, 2009
12:00-1:00 p.m. ET (Dr. Silva/Dr. Roth)

Featured Article: Silva GE, An M, Goodwin J, et al. Longitudinal evaluation of sleep-disordered breathing and sleep symptoms with change in quality of life: the Sleep Heart Health Study (SHHS). Sleep 2009;32:11049-11057.

> View activity details
> View abstract
> Add to calendar
> Register now

PART 3: Monday, October 19, 2009
12:00-1:00 p.m. ET (Dr. Garcia-Rill/Dr. Roth)

Featured Article: Beck P, Odle A, Wallace-Huitt T, Skinner R, Garcia-Rill E. Modafinil increases arousal determined by P13 potential amplitude: an effect blocked by gap junction antagonists. Sleep 2008;31:1647-1654.

> View activity details
> View abstract
> Add to calendar
> Register now

Statement of Need
Evolving research in the field of sleep-wake medicine has offered insights regarding the linkage between sleep disturbances and adverse consequences related to performance, mood, behavior, and medical illness…

> Read more

Learning Objectives
At the end of each CE activity, participants should be able to:

• PART 1: Recognize the relationship between genetics and individual differences in susceptibility to sleep loss and circadian misalignment.
• PART 2: Assess the impact of sleep disordered breathing, sleep quality, and excessive sleepiness on physical and mental quality of life.
• PART 3: Link the neuronal process of electrical coupling to sleep-wake control.

Credit Information
Earn up to 3.0 CE credits by completing all 3 parts!
This series offers CE credit for:

• Physicians (ACCME/AMA PRA Category 1)
• Nurses (CNE)
• Pharmacists (ACPE)
• Psychologists (APA)
• Social Workers (NASW)
• Certified Case Managers (CCMC)

All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.

> Back to top